Medical Article

Viridian Therapeutics’ Lumvoa is approved for treating both the chronic and active phases of thyroid eye disease. This drug will offer patients an alternative to Tepezza, an Amgen drug that had been the only approved therapy for this inflammatory eye disorder. The post FDA Approves Viridian’s Thyroid Eye Disease Drug, Competitor to a Blockbuster Amgen…

CMS is recalculating some 2026 Medicare Advantage Star Ratings after a court ruled it improperly calculated Clover Health’s rating, a decision that could boost payments for a small number of insurers. The post CMS Recalculates Star Ratings — Again appeared first on MedCity News.

For seniors, the change in policy will dramatically expand access to a revolutionary medication. But there are also significant risks. The post A Bridge to Nowhere?  Medicare’s GLP-1 Coverage Expansion Requires A More Holistic Approach To Weight Management appeared first on MedCity News.

Before policymakers, employers, insurers, or taxpayers commit ever-larger sums to the system, an uncomfortable question deserves attention: How much additional capacity does healthcare actually need and what measurable outcomes should society expect in return? The post Healthcare’s Most Avoided Question: “How Much Exactly Do You Need, and What Will America Get in Return?” appeared first…

Cultivating a positive culture is a priority for hospital leaders, but many are making avoidable mistakes. Myra Gregorian, Seattle Children’s chief people and transformation officer, outlined some of these common blunders — such as not involving frontline staff in decision making and assuming that simple communication methods are sufficient. The post 3 Traps Health Systems…

While the Pap identifies the cell changes, the HPV test determines the root cause before those changes even happen. Both tests have saved lives. But they are not interchangeable, and treating them as such puts the patient at risk.  The post The Terminology Gap Undermining Cervical Cancer Screening Guidelines appeared first on MedCity News.